RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Resources Pharmaceutical Group Stock

China Resources Pharmaceutical Group Equity 2024

China Resources Pharmaceutical Group Equity

45.96 B CNY

Ticker

3320.HK

ISIN

HK0000311099

WKN

A2ATTU

In 2024, China Resources Pharmaceutical Group's equity was 45.96 B CNY, a 5.52% increase from the 43.56 B CNY equity in the previous year.

China Resources Pharmaceutical Group Aktienanalyse

What does China Resources Pharmaceutical Group do?

China Resources Pharmaceutical Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing China Resources Pharmaceutical Group's Equity

China Resources Pharmaceutical Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding China Resources Pharmaceutical Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating China Resources Pharmaceutical Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

China Resources Pharmaceutical Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in China Resources Pharmaceutical Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about China Resources Pharmaceutical Group stock

What is the equity of China Resources Pharmaceutical Group this year?

China Resources Pharmaceutical Group has equity of 45.96 B CNY this year.

What was the equity of China Resources Pharmaceutical Group compared to the previous year?

The equity of China Resources Pharmaceutical Group has increased/decreased by 5.52% increased compared to the previous year.

What impact does a high equity have on investors of China Resources Pharmaceutical Group?

A high equity is advantageous for investors of China Resources Pharmaceutical Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of China Resources Pharmaceutical Group?

A low equity can be a risk for investors of China Resources Pharmaceutical Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of China Resources Pharmaceutical Group affect the company?

An increase in equity of China Resources Pharmaceutical Group can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of China Resources Pharmaceutical Group affect the company?

A reduction in equity of China Resources Pharmaceutical Group can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of China Resources Pharmaceutical Group?

Some factors that can affect the equity of China Resources Pharmaceutical Group include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of China Resources Pharmaceutical Group so important for investors?

The equity of China Resources Pharmaceutical Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can China Resources Pharmaceutical Group take to change the equity?

To change equity, China Resources Pharmaceutical Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does China Resources Pharmaceutical Group pay?

Over the past 12 months, China Resources Pharmaceutical Group paid a dividend of 0.16 CNY . This corresponds to a dividend yield of about 3.63 %. For the coming 12 months, China Resources Pharmaceutical Group is expected to pay a dividend of 0.17 CNY.

What is the dividend yield of China Resources Pharmaceutical Group?

The current dividend yield of China Resources Pharmaceutical Group is 3.63 %.

When does China Resources Pharmaceutical Group pay dividends?

China Resources Pharmaceutical Group pays a quarterly dividend. This is distributed in the months of July, July, October, October.

How secure is the dividend of China Resources Pharmaceutical Group?

China Resources Pharmaceutical Group paid dividends every year for the past 12 years.

What is the dividend of China Resources Pharmaceutical Group?

For the upcoming 12 months, dividends amounting to 0.17 CNY are expected. This corresponds to a dividend yield of 3.84 %.

In which sector is China Resources Pharmaceutical Group located?

China Resources Pharmaceutical Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Resources Pharmaceutical Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Resources Pharmaceutical Group from 10/30/2024 amounting to 0.01 CNY, you needed to have the stock in your portfolio before the ex-date on 9/12/2024.

When did China Resources Pharmaceutical Group pay the last dividend?

The last dividend was paid out on 10/30/2024.

What was the dividend of China Resources Pharmaceutical Group in the year 2023?

In the year 2023, China Resources Pharmaceutical Group distributed 0.15 CNY as dividends.

In which currency does China Resources Pharmaceutical Group pay out the dividend?

The dividends of China Resources Pharmaceutical Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Resources Pharmaceutical Group

Our stock analysis for China Resources Pharmaceutical Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Resources Pharmaceutical Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.